Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
In the 2021 STEP-1 trial (1,961 adults with obesity or overweight), participants receiving semaglutide plus lifestyle intervention experienced a 14.9% mean weight loss after 68 weeks, while those on placebo lost only 2.4%
Data from the SURMOUNT-3 trial, published in Nature Medicine, supports this, noting that the safety profile of tirzepatide at maximum tolerated doses remained consistent with prior phases of the programme
Be sure to find humanely raised, grass-fed sources of these meat products
Your privacy is our priority, and we take every measure to ensure the protection of your sensitive data
US$ 21.39
US$ 20.60
US$ 21.07
US$ 25.49
